Edition:
United Kingdom

Biotechnology & Medical Research

Health Canada Grants Market Authorization For ORKAMBI (Lumacaftor/Ivacaftor) For Children With Cystic Fibrosis Aged 2 To 5 Years Old With Most Common Form Of The Disease

Dec 13 (Reuters) - Vertex Pharmaceuticals Inc ::HEALTH CANADA GRANTS MARKET AUTHORIZATION FOR ORKAMBI® (LUMACAFTOR/IVACAFTOR) FOR CHILDREN WITH CYSTIC FIBROSIS AGED 2 TO 5 YEARS OLD WITH MOST COMMON FORM OF THE DISEASE.VERTEX PHARMACEUTICALS INC - EXPECTS A DECISION ON ORKAMBI FROM EUROPEAN...

1:00pm GMT

Altimmune Announces Clinical Program Updates And Plans For Pipeline Expansion

Dec 13 (Reuters) - Altimmune Inc ::ALTIMMUNE ANNOUNCES CLINICAL PROGRAM UPDATES AND PLANS FOR PIPELINE EXPANSION.ALTIMMUNE INC - ADVANCING MANUFACTURE OF A MULTIVALENT FORMULATION AND INTENDS TO INITIATE ADDITIONAL PHASE 2 STUDIES ONCE MANUFACTURING IS COMPLETE.ALTIMMUNE - CONDUCTING EXTENSION STUDY...

12:01pm GMT

Bellicum Pharmaceuticals Appoints Atabak Mokari As CFO

Dec 13 (Reuters) - Bellicum Pharmaceuticals Inc ::BELLICUM PHARMACEUTICALS APPOINTS ATABAK MOKARI AS CHIEF FINANCIAL OFFICER.BELLICUM PHARMACEUTICALS INC - APPOINTMENT OF ATABAK MOKARI AS CHIEF FINANCIAL OFFICER, EFFECTIVE DECEMBER 19.BELLICUM PHARMACEUTICALS INC - MOKARI JOINS BELLICUM FROM IRIDEX...

12:00pm GMT

Proqr Announces Strategic Changes To The Management Team And Key New Hires

Dec 13 (Reuters) - ProQR Therapeutics NV ::PROQR ANNOUNCES STRATEGIC CHANGES TO THE MANAGEMENT TEAM AND KEY NEW HIRES.PROQR THERAPEUTICS NV - SMITAL SHAH IS PROMOTED TO CHIEF BUSINESS AND FINANCIAL OFFICER.

12:00pm GMT

Expansion & New Markets

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.